Masimo

Company

Investment-firm

Last deal

$750M

Amount

Post-IPO Equity

Stage

15.08.2022

Date

4

all rounds

$755M

Total amount

General

About Company
Masimo is a medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1989

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Masimo's products include pulse oximetry and blood constituent monitoring technologies that provide accurate and reliable measurements for healthcare providers. Their technologies have been proven to be effective even in challenging clinical conditions, such as patient motion and low peripheral perfusion. With a focus on improving patient outcomes and reducing the cost of care, Masimo's portfolio of products leads the way in innovation, performance, and patient safety. They sell their products directly to end-users and also collaborate with original equipment manufacturers to incorporate their technologies into other medical devices.
Contacts

Social url